This model permits the loss of NEU (ERBB2) expression in a pre-established NEU-driven mammary tumor, and therefore provides researchers with a unique tool for study of the molecular mechanisms that control tumor dormancy and re-emergence from the dormant state81. The gene discussed is ERBB2; the disease is breast cancer.